Lymphadenectomy for Gastric Cancer

Area of Science:

• Surgical Oncology
• Gastroenterology
• Clinical Trials

Background:

• Gastric cancer management relies on a multidisciplinary approach combining systemic therapy and surgical intervention.
• Lymphadenectomy is crucial for accurate staging in gastric cancer patients.
• Evidence regarding the necessity of extended lymphadenectomy (e.g., D2) remains debated, with conflicting trial results.

Purpose of the Study:

• To evaluate the necessity and impact of extended lymphadenectomy in gastric cancer surgery.
• To determine optimal lymph node retrieval for accurate gastric cancer staging.
• To assess the morbidity associated with specific surgical techniques for lymph node dissection.

Main Methods:

• Review of retrospective, prospective, and randomized trials on lymphadenectomy in gastric cancer.
• Analysis of current guidelines for lymph node retrieval in gastric cancer staging.
• Evaluation of surgical techniques, including D1 and D2 lymphadenectomy, and associated procedures like distal pancreatectomy and splenectomy.

Main Results:

• Conflicting evidence exists regarding the benefits of extended lymphadenectomy.
• Current guidelines recommend harvesting a minimum of 16 lymph nodes for accurate staging.
• Extensive D2 lymphadenectomy does not necessitate distal pancreatectomy and splenectomy, which are associated with increased patient morbidity.

Conclusions:

• Accurate staging of gastric cancer requires retrieval of at least 16 lymph nodes.
• While D1 lymphadenectomy may suffice, D2 lymphadenectomy might be necessary in some cases.
• Distal pancreatectomy and splenectomy are not required for maximizing D2 nodal harvest and should be avoided to minimize surgical morbidity.